Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Auteurs » - entrée « Daihei Kida »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Daigo Akahane < Daihei Kida < Daijiro Kabata  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
001013 (2015) Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
001397 (2014) Shinya Hirabara [Japon] ; Nobunori Takahashi ; Naoki Fukaya ; Hiroyuki Miyake ; Yuichiro Yabe ; Atsushi Kaneko ; Takayasu Ito ; Takeshi Oguchi ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Fumiaki Sugiura ; Masatoshi Hayashi ; Koji Funahashi ; Masahiro Hanabayashi ; Shuji Asai ; Naoki Ishiguro ; Toshihisa KojimaClinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies.
001398 (2014) Nobunori Takahashi [Japon] ; Toshihisa Kojima ; Atsushi Kaneko ; Daihei Kida ; Yuji Hirano ; Takayoshi Fujibayashi ; Yuichiro Yabe ; Hideki Takagi ; Takeshi Oguchi ; Hiroyuki Miyake ; Takefumi Kato ; Naoki Fukaya ; Hisato Ishikawa ; Masatoshi Hayashi ; Seiji Tsuboi ; Yasuhide Kanayama ; Daizo Kato ; Koji Funahashi ; Hiroyuki Matsubara ; Yosuke Hattori ; Masahiro Hanabayashi ; Shinya Hirabara ; Kenya Terabe ; Yutaka Yoshioka ; Naoki IshiguroClinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
001556 (2013) Toshihisa Kojima [Japon] ; Yuichiro Yabe ; Atsushi Kaneko ; Yuji Hirano ; Hisato Ishikawa ; Masatoshi Hayashi ; Hiroyuki Miyake ; Hideki Takagi ; Takefumi Kato ; Kenya Terabe ; Tsuyoshi Wanatabe ; Hiroki Tsuchiya ; Daihei Kida ; Tomone Shioura ; Koji Funahashi ; Daizo Kato ; Hiroyuki Matsubara ; Nobunori Takahashi ; Yosuke Hattori ; Nobuyuki Asai ; Naoki IshiguroMonitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
001792 (2012) Atsushi Kaneko [Japon] ; Daihei Kida ; Kiwamu Saito ; Masami Tsukamoto ; Tomotaro SatoClinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Daihei Kida" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "Daihei Kida" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Daihei Kida
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021